Cargando…

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

BACKGROUND: Indobufen can reversibly inhibit platelet aggregation and showed to be effective in the treatment of ischaemic heart and peripheral vascular diseases. However, it is unclear whether indobufen is an alternative antiplatelet agent for treatment of patients with ischaemic stroke. AIM: To te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yuesong, Meng, Xia, Chen, Weiqi, Jing, Jing, Lin, Jinxi, Jiang, Yong, Johnston, S Claiborne, Bath, Philip M, Dong, Qiang, Xu, An-Ding, Li, Hao, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614137/ https://www.ncbi.nlm.nih.gov/pubmed/35393360 http://dx.doi.org/10.1136/svn-2021-001480

Ejemplares similares

Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Publicado: (2023)

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
por: Wang, Yongjun, et al.
Publicado: (2021)

Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)
por: Gao, Ying, et al.
Publicado: (2023)

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
por: Wang, Yongjun, et al.
Publicado: (2019)

Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry
por: Wang, Yongjun, et al.
Publicado: (2020)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial
por: Xie, Xuewei, et al.
Publicado: (2023)

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
por: Tank, Amarjeet, et al.
Publicado: (2023)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
por: Li, Shuya, et al.
Publicado: (2021)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018)

Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
por: Suo, Yue, et al.
Publicado: (2020)

Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network
por: Tettamanti, Mauro, et al.
Publicado: (2020)

Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin
por: Wang, Peng, et al.
Publicado: (2020)

Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings
por: Wang, Yongjun, et al.
Publicado: (2018)

Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China
por: Li, Zixiao, et al.
Publicado: (2022)

Acute Ischaemic Stroke Cooperation Group of Endovascular Treatment (ANGEL) registry: study protocol for a prospective, multicentre registry in China
por: Huo, Xiaochuan, et al.
Publicado: (2019)

LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)

Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging
por: Wang, Yu, et al.
Publicado: (2022)

Whole genome sequencing of 10K patients with acute ischaemic stroke or transient ischaemic attack: design, methods and baseline patient characteristics
por: Cheng, Si, et al.
Publicado: (2020)

Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial
por: Liu, Liping, et al.
Publicado: (2023)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016)

Mind the Heart: Electrocardiography-gated cardiac computed tomography-angiography in acute ischaemic stroke—rationale and study design
por: Guglielmi, Valeria, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial
por: Wang, Yongjun, et al.
Publicado: (2021)

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
por: Liu, Liping, et al.
Publicado: (2021)

PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)—a population-based prospective cohort study: rationale, design and baseline participant characteristics
por: Pan, Yuesong, et al.
Publicado: (2020)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
por: Shi, Qiu-Ping, et al.
Publicado: (2022)

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial
por: Zhou, Mengyuan, et al.
Publicado: (2020)

Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack
por: Zhou, Hongyu, et al.
Publicado: (2021)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
por: Rothwell, Peter M, et al.
Publicado: (2016)

Data-driven clustering approach to identify novel phenotypes using multiple biomarkers in acute ischaemic stroke: A retrospective, multicentre cohort study
por: Ding, Lingling, et al.
Publicado: (2022)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Zhang, Lei, et al.
Publicado: (2021)

Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
por: Clancy, Una, et al.
Publicado: (2020)

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
por: Li, Shuya, et al.
Publicado: (2021)

Inconsistent centralised versus non-centralised ischaemic stroke aetiology
por: Suo, Yue, et al.
Publicado: (2020)

Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial
por: Huo, Xiaochuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mptn9m5q4r2okefi8tncqie9c0